These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33156106)

  • 41. Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial.
    Barret M; Pioche M; Terris B; Ponchon T; Cholet F; Zerbib F; Chabrun E; Le Rhun M; Coron E; Giovannini M; Caillol F; Laugier R; Jacques J; Legros R; Boustiere C; Rahmi G; Metivier-Cesbron E; Vanbiervliet G; Bauret P; Escourrou J; Branche J; Jilet L; Abdoul H; Kaddour N; Leblanc S; Bensoussan M; Prat F; Chaussade S
    Gut; 2021 Jun; 70(6):1014-1022. PubMed ID: 33685969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression.
    Klaver E; Bureo Gonzalez A; Mostafavi N; Mallant-Hent R; Duits LC; Baak B; Böhmer CJM; van Oijen AHAM; Naber T; Scholten P; Meijer SL; Bergman JJGHM; Pouw RE;
    United European Gastroenterol J; 2021 Oct; 9(8):929-937. PubMed ID: 34228885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.
    Harrison R; Perry I; Haddadin W; McDonald S; Bryan R; Abrams K; Sampliner R; Talley NJ; Moayyedi P; Jankowski JA
    Am J Gastroenterol; 2007 Jun; 102(6):1154-61. PubMed ID: 17433019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of body mass index on the prevalence and progression of dysplasia in Barrett's esophagus: a retrospective analysis (.).
    Thota PN; Arora Z; Benjamin T; Pagadala M; Lopez R; Sanaka MR
    Scand J Gastroenterol; 2016 Nov; 51(11):1288-93. PubMed ID: 27460942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
    Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
    Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimized Surveillance Intervals Following Endoscopic Eradication of Dysplastic Barrett's Esophagus: An International Cohort Study.
    Kahn A; Crook J; Heckman MG; Wieczorek MA; Sami S; Snyder D; Agarwal S; Santiago J; Fernandez-Sordo JO; Tan WK; Lansing R; Wang KK; Ragunath K; DiPietro M; Wolfsen H; Ramirez F; Fleischer D; Leggett CL; Iyer PG
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2763-2771.e3. PubMed ID: 35245702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
    Rana PS; Johnston DA
    Dis Esophagus; 2000; 13(1):28-31. PubMed ID: 11005328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma.
    Grant KS; DeMeester SR; Kreger V; Oh D; Hagen JA; Chandrasoma P; DeMeester TR
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):31-7. PubMed ID: 23312980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus.
    Sharma P; Weston AP; Topalovski M; Cherian R; Bhattacharyya A; Sampliner RE
    Gut; 2003 Jan; 52(1):24-7. PubMed ID: 12477754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Real-time diagnosis of Barrett's esophagus: a prospective, multicenter study comparing confocal laser endomicroscopy with conventional histology for the identification of intestinal metaplasia in new users.
    Richardson C; Colavita P; Dunst C; Bagnato J; Billing P; Birkenhagen K; Buckley F; Buitrago W; Burnette J; Leggett P; McCollister H; Stewart K; Wang T; Zfass A; Severson P
    Surg Endosc; 2019 May; 33(5):1585-1591. PubMed ID: 30203202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).
    Sharma VK; Kim HJ; Das A; Dean P; DePetris G; Fleischer DE
    Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magnification endoscopy and chromoendoscopy in evaluation of specialized intestinal metaplasia in Barrett's Esophagus.
    Wasielica-Berger J; Baniukiewicz A; Wroblewski E; Chwiesko A; Dabrowski A
    Dig Dis Sci; 2011 Jul; 56(7):1987-95. PubMed ID: 21225343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate.
    Ooi J; Wilson P; Walker G; Blaker P; DeMartino S; O'Donohue J; Reffitt D; Lanaspre E; Chang F; Meenan J; Dunn JM
    Endoscopy; 2017 Jun; 49(6):524-528. PubMed ID: 28399610
    [No Abstract]   [Full Text] [Related]  

  • 55. Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports.
    Curvers WL; Peters FP; Elzer B; Schaap AJ; Baak LC; van Oijen A; Mallant-Hent RM; Ten Kate F; Krishnadath KK; Bergman JJ
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):601-7. PubMed ID: 18679060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
    Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ
    J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma.
    Hillman LC; Chiragakis L; Clarke AC; Kaushik SP; Kaye GL
    J Gastroenterol Hepatol; 2003 May; 18(5):526-33. PubMed ID: 12702044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Columnar-celled metaplasia and adenocarcinoma of the esophagus in inhabitants of the Leningrad oblast (by the data of esophagogastroduodenoscopy)].
    Vasilevskiĭ DI; Silant'ev DS; Mikhaleva KV; Priadko AS; Filin AV; Vorob'ev SL; Mednikov SN; Luft AV; Kulagin VI; Bagnenko SF
    Vestn Khir Im I I Grek; 2012; 171(6):76-9. PubMed ID: 23488270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Barrett's esophagus: diagnosis and therapy].
    Schmassmann A; Gebbers JO
    Praxis (Bern 1994); 2005 May; 94(21):861-8. PubMed ID: 15966485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.